JUNS · NASDAQ
Jupiter Neurosciences (JUNS) Stock Price & Fundamentals
Jupiter Neurosciences (JUNS) closed at $702.45 on Oct 9, 2026, down 0.49% from the previous close of $705.92.
Share price, past year
1Y +28.28%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $702.45 |
| Sep 30, 2026 | $715.98 |
| Aug 31, 2026 | $678.73 |
| Jul 31, 2026 | $679.84 |
| Jun 30, 2026 | $673.45 |
| May 29, 2026 | $639.98 |
| Apr 30, 2026 | $624.98 |
| Mar 31, 2026 | $643.75 |
| Feb 27, 2026 | $638.19 |
| Jan 30, 2026 | $593.96 |
| Dec 31, 2025 | $558.60 |
| Nov 28, 2025 | $556.51 |
| Oct 31, 2025 | $535.58 |
Key statistics
- Market cap
- $466.90M
- P/E (TTM)
- 936.6
- EPS (TTM)
- $0.75
- Revenue (TTM)
- —
- Net income (TTM)
- −$9.20M
- Shares outstanding
- 664.7K
- Dividend yield
- —
- 52-week range
- $535.23 – $722.50
Jupiter Neurosciences's market cap is $466.90M, based on a share price of $702.45 and 664.7K shares outstanding as of Jun 30, 2026.
Financials
Jupiter Neurosciences reported revenue of $21.80K for fiscal 2025.
Jupiter Neurosciences reported a net loss of $8.64M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $21.80K | — | −$8.64M | −39,662.8% | −$0.25 | — |
| FY2024ended Dec 31, 2024 | $0.00 | — | −$2.44M | — | −$0.08 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $24.25K | −$2.27M | −$4.08 |
| Q1 FY2026ended Mar 31, 2026 | $18.65K | −$2.06M | −$0.06 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$1.53M | −$0.05 |
Company profile
- Name
- Jupiter Neurosciences, Inc.
- Ticker
- JUNS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1001 North Us Hwy 1, Suite 504, Jupiter, FL 33477
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001679628
Recent SEC filings
- Sep 3, 2026
- Aug 28, 2026
- Aug 27, 2026
- Aug 24, 2026
- Aug 24, 2026
- Aug 14, 2026
- Aug 6, 2026
- Jul 28, 2026
Frequently asked questions
What is Jupiter Neurosciences's stock price?
Jupiter Neurosciences (JUNS) closed at $702.45 on Oct 9, 2026, down 0.49% from the previous close of $705.92.
What is Jupiter Neurosciences's market cap?
Jupiter Neurosciences's market cap is $466.90M, based on a share price of $702.45 and 664.7K shares outstanding as of Jun 30, 2026.
How much revenue does Jupiter Neurosciences make?
Jupiter Neurosciences reported revenue of $21.80K for fiscal 2025.
What is JUNS's P/E ratio?
Jupiter Neurosciences's price-to-earnings ratio is 936.6, based on trailing twelve-month diluted EPS of $0.75.
Does Jupiter Neurosciences pay a dividend?
Jupiter Neurosciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Jupiter Neurosciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures